Narodny Ustav Detskych Chorob

The site investigates treatments for serious bacterial and fungal infections in children, aiming to improve safety and effectiveness.

• Complicated urinary tract infections
• Acute bacterial sepsis
• Hospital‑acquired fungal infections

Research includes evaluating new antimicrobial agents and optimizing dosing strategies to reduce infection‑related complications.

Studies focus on rare inherited disorders that affect infants and children, seeking better therapeutic options.

• Osteogenesis Imperfecta
• Primary Immunodeficiency Diseases
• Genetic metabolic syndromes

Trials assess gene‑targeted therapies and immune‑supportive products to enhance growth and immune function.

Pediatric eye health is addressed through trials that aim to slow disease progression and improve visual outcomes.

• Myopia progression
• Pediatric uveitis
• Congenital cataract

The research evaluates novel ophthalmic solutions and device‑based interventions to preserve vision.

The clinic conducts extensive research on blood‑related cancers, testing innovative therapies to increase survival rates.

• Acute Lymphoblastic Leukaemia
• Lymphoblastic lymphoma
• Anaplastic Large Cell Lymphoma
• Neuroblastoma
• Rhabdomyosarcoma
• Ewing sarcoma

Efforts include immunotherapy, targeted agents, and stem‑cell transplantation to improve long‑term remission.

Trials target disorders of immune regulation, aiming to restore balance and reduce disease activity.

• Multiple Sclerosis
• Atopic Dermatitis
• Primary Immunodeficiency Diseases

Studies compare novel biologics with existing standards to determine superior efficacy and safety.

Research seeks to strengthen bone health and reduce fracture risk in children with skeletal fragility.

• Osteogenesis Imperfecta
• Juvenile idiopathic arthritis
• Muscular dystrophy

Investigations include bone‑forming agents and rehabilitation protocols to enhance mobility.

A broad portfolio of cancer trials evaluates cutting‑edge treatments across solid and hematologic tumors in young patients.

• Hepatoblastoma
• High‑risk neuroblastoma
• Relapsed acute lymphoblastic leukemia
• Metastatic sarcomas

The program emphasizes personalized medicine, combining targeted drugs with conventional chemotherapy.

Neurological conditions are studied to improve function and quality of life for affected children.

• Multiple Sclerosis
• Chronic Migraine
• Neurogenic Detrusor Overactivity

Trials test neuromodulators and disease‑modifying therapies to reduce symptom burden.

Metabolic health research addresses obesity and related disorders to promote healthier growth trajectories.

• Obesity
• Type 2 Diabetes
• Metabolic syndrome

Interventions include lifestyle programs and novel metabolic agents aimed at weight management.

Studies focus on common pediatric symptoms to develop better diagnostic tools and symptom‑relief strategies.

• Atopic Dermatitis
• Chronic Migraine
• Painful urination

The work integrates patient‑reported outcomes to tailor therapies to individual needs.

Dermatologic trials aim to control inflammation and prevent long‑term skin damage in children.

• Atopic Dermatitis
• Pediatric psoriasis
• Connective tissue disorders

Innovative topical agents and systemic treatments are evaluated for safety and rapid symptom control.

Viral infection research, especially COVID‑19, seeks effective treatments for immunocompromised children.

• COVID‑19
• Pediatric influenza
• Viral gastroenteritis

Studies assess antiviral combinations and immune‑boosting strategies to reduce severe outcomes.

Fundamental investigations explore how the immune system functions in health and disease, guiding future therapeutic design.

• Immune cell signaling
• Complement pathway regulation
• Cytokine storm mitigation

Findings support the development of next‑generation immunomodulators for pediatric use.